CLINICAL_TRIALS
trial_result
· 2013-06-21
Clinical Trial Update: Aminocamptothecin in Treating Patients With Advanced or Recurrent Kidney Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating aminocamptothecin for advanced or recurrent kidney cancer has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED